Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Laughton

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
AIDS (London, England)|March 10, 2016
HIV-associated CD4+/CD8+ depletion in infancy is associated with neurometabolic reductions in the basal ganglia at age 5 years despite early antiretroviral therapyKenneth K Mbugua, Martha J Holmes, Mark F Cotton, et al.
Human Brain Mapping|May 16, 2022
Multimodal magnetic resonance neuroimaging measures characteristic of early cART-treated pediatric HIV: A feature selection approachIsaac L Khobo, Marcin Jankiewicz, Martha J Holmes, et al.
Journal of the International AIDS Society|May 4, 2018
Five year neurodevelopment outcomes of perinatally HIV-infected children on early limited or deferred continuous antiretroviral therapyBarbara Laughton, Morna Cornell, Martin Kidd, et al.
Frontiers in Human Neuroscience|January 30, 2018
Functional Connectivity Alterations between Networks and Associations with Infant Immune Health within Networks in HIV Infected Children on Early Treatment: A Study at 7 YearsJadrana T F Toich, Paul A Taylor, Martha J Holmes, et al.
Frontiers in Pediatrics|August 22, 2022
Antiretroviral choice and severe disease predict poorer neuropsychological outcomes in HIV+ children from AfricaLee Fairlie, Miriam Chernoff, Mark F Cotton, et al.
AIDS (London, England)|May 23, 2012
Early antiretroviral therapy improves neurodevelopmental outcomes in infantsBarbara Laughton, Morna Cornell, Debbie Grove, et al.
Frontiers in Neuroscience|March 27, 2023
Maternal ART throughout gestation prevents caudate volume reductions in neonates who are HIV exposed but uninfectedAbdulmumin Ibrahim, Fleur L Warton, Samantha Fry, et al.
Plos One|February 22, 2024
Multi-modal analysis of inflammation as a potential mediator of depressive symptoms in young people with HIV: The GOLD depression studyArish Mudra Rakshasa-Loots, Shalena Naidoo, Thandi Hamana, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 2, 2021
South African Children: A Matched Cohort Study of Neurodevelopmental Impairment in Survivors of Invasive Group B Streptococcus Disease Aged 5 to 8 YearsLois M Harden, Shannon Leahy, Sanjay G Lala, et al.
BMJ Open|January 2, 2023
Survival and health of children who are HIV-exposed uninfected: study protocol for the CHERISH (Children HIV-Exposed Uninfected - Research to Inform Survival and Health) dynamic, prospective, maternal-child cohort studyAmy L Slogrove, Shani Tamlyn de Beer, Emma Kalk, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
AIDS (London, England)|March 10, 2016
HIV-associated CD4+/CD8+ depletion in infancy is associated with neurometabolic reductions in the basal ganglia at age 5 years despite early antiretroviral therapyKenneth K Mbugua, Martha J Holmes, Mark F Cotton, et al.
Human Brain Mapping|May 16, 2022
Multimodal magnetic resonance neuroimaging measures characteristic of early cART-treated pediatric HIV: A feature selection approachIsaac L Khobo, Marcin Jankiewicz, Martha J Holmes, et al.
Journal of the International AIDS Society|May 4, 2018
Five year neurodevelopment outcomes of perinatally HIV-infected children on early limited or deferred continuous antiretroviral therapyBarbara Laughton, Morna Cornell, Martin Kidd, et al.
Frontiers in Human Neuroscience|January 30, 2018
Functional Connectivity Alterations between Networks and Associations with Infant Immune Health within Networks in HIV Infected Children on Early Treatment: A Study at 7 YearsJadrana T F Toich, Paul A Taylor, Martha J Holmes, et al.
Frontiers in Pediatrics|August 22, 2022
Antiretroviral choice and severe disease predict poorer neuropsychological outcomes in HIV+ children from AfricaLee Fairlie, Miriam Chernoff, Mark F Cotton, et al.
AIDS (London, England)|May 23, 2012
Early antiretroviral therapy improves neurodevelopmental outcomes in infantsBarbara Laughton, Morna Cornell, Debbie Grove, et al.
Frontiers in Neuroscience|March 27, 2023
Maternal ART throughout gestation prevents caudate volume reductions in neonates who are HIV exposed but uninfectedAbdulmumin Ibrahim, Fleur L Warton, Samantha Fry, et al.
Plos One|February 22, 2024
Multi-modal analysis of inflammation as a potential mediator of depressive symptoms in young people with HIV: The GOLD depression studyArish Mudra Rakshasa-Loots, Shalena Naidoo, Thandi Hamana, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 2, 2021
South African Children: A Matched Cohort Study of Neurodevelopmental Impairment in Survivors of Invasive Group B Streptococcus Disease Aged 5 to 8 YearsLois M Harden, Shannon Leahy, Sanjay G Lala, et al.
BMJ Open|January 2, 2023
Survival and health of children who are HIV-exposed uninfected: study protocol for the CHERISH (Children HIV-Exposed Uninfected - Research to Inform Survival and Health) dynamic, prospective, maternal-child cohort studyAmy L Slogrove, Shani Tamlyn de Beer, Emma Kalk, et al.
Pageof 8